Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00209703
Status:
TERMINATED
Last Update Posted:
2006-04-21
First Post:
2005-09-13
Brief Title:
Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer
Sponsor:
Hokkaido Gastrointestinal Cancer Study Group
Organization:
Hokkaido Gastrointestinal Cancer Study Group
Study Overview
Official Title:
Feasibility Study of mFOLFOX6 Oxaliplatin Combined With l-Leucovorin l-LV and 5-Fluorouracil in Patients With Advanced Colorectal Cancer
Status:
TERMINATED
Status Verified Date:
2006-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We performed a feasibility study of mFOLFOX6 in advanced colorectal cancer in Japan and to estimate the safety and efficacy of this regimen
Detailed Description:
A multicenter Open-label single-arm feasibility study is conducted on patients with histological stage IV colorectal cancer given oxaliplatin leucovorin plus fluorouracil The usefulness of this regimens as therapy for colorectal cancer was evaluated by the disease-free survival rate DFR overall survival rate OS incidence and severity of adverse event
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None